Short Interest in CV Sciences, Inc. (OTCMKTS:CVSI) Decreases By 50.6%

CV Sciences, Inc. (OTCMKTS:CVSI) was the target of a significant decrease in short interest in February. As of February 13th, there was short interest totaling 6,360 shares, a decrease of 50.6% from the January 29th total of 12,867 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average trading volume of 2,403,529 shares, the days-to-cover ratio is currently 0.0 days. Based on an average trading volume of 2,403,529 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the company’s stock are short sold.

CV Sciences Stock Down 0.9%

CVSI opened at $0.07 on Friday. The company has a fifty day moving average price of $0.05 and a two-hundred day moving average price of $0.04. CV Sciences has a 1-year low of $0.02 and a 1-year high of $0.10. The company has a quick ratio of 0.21, a current ratio of 1.07 and a debt-to-equity ratio of 0.33.

CV Sciences Company Profile

CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.

Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.